Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin -The CLEAR PLATELETS-2 Study

Trial Profile

Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin -The CLEAR PLATELETS-2 Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Bivalirudin; Eptifibatide
  • Indications Coronary artery disease; Embolism and thrombosis
  • Focus Biomarker; Pharmacodynamics
  • Acronyms CLEAR-PLATELETS-2
  • Most Recent Events

    • 24 Feb 2009 Results published in Journal of the American College of Cardiology 53: 648-657, No. 8, 24 Feb 2009.
    • 06 Nov 2007 Status changed from recruiting to completed.
    • 06 Jul 2007 Interim results have been presented.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top